Core Scientific, Common Stock Performance
| CORZ Stock | USD 11.16 0.45 4.20% |
The firm shows a Beta (market volatility) of 1.19, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Core Scientific, will likely underperform. At this point, Core Scientific, Common has a negative expected return of -0.45%. Please make sure to confirm Core Scientific,'s jensen alpha, kurtosis, as well as the relationship between the Kurtosis and price action indicator , to decide if Core Scientific, Common performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Core Scientific, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Actual Historical Performance (%)
One Day Return 4.2 | Five Day Return 3.05 | Year To Date Return (22.93) | Ten Year Return 224.42 | All Time Return 224.42 |
1 | Disposition of 267301 shares by Todd DuChene of Core Scientific, at 0.01 subject to Rule 16b-3 | 12/12/2024 |
2 | Acquisition by Levitt Michael J of 810232 shares of Core Scientific, at 6.81 subject to Rule 16b-3 | 12/23/2024 |
3 | Acquisition by Todd DuChene of 55758 shares of Core Scientific, subject to Rule 16b-3 | 12/31/2024 |
4 | Disposition of 2949 shares by Todd DuChene of Core Scientific, at 14.5682 subject to Rule 16b-3 | 01/03/2025 |
5 | Disposition of 802 shares by Denise Sterling of Core Scientific, at 15.641 subject to Rule 16b-3 | 01/22/2025 |
6 | Disposition of 25277 shares by Todd DuChene of Core Scientific, at 16.2 subject to Rule 16b-3 | 01/24/2025 |
7 | Core Scientific, Inc. Positioned for AI Growth with High-Performance Computing and Strategic Infrastructure | 01/27/2025 |
8 | Core Scientific Inc Releases January 2025 Bitcoin Mining and Operations Update | 02/05/2025 |
9 | Core Scientific Among Hot Tech Stocks to Buy Right Now | 02/07/2025 |
10 | Looking At Core Scientifics Recent Unusual Options Activity | 02/12/2025 |
11 | Beryl Capital Management LLC Reduces Stake in Seaport Entertainment Group Inc | 02/14/2025 |
12 | Core Scientific Inc Expands High-Performance Computing Facility in Auburn, Alabama | 02/20/2025 |
13 | Core Scientific Inc Trading Down 8.7 percent on Feb 25 | 02/25/2025 |
14 | Core Scientific Inc Reports Q4 2024 Financial Results Amid Strategic Growth Initiatives | 02/26/2025 |
15 | Why Core Scientific, Inc. is Plunging So Far in 2025 | 02/28/2025 |
| Begin Period Cash Flow | 52.2 M |
Core |
Core Scientific, Relative Risk vs. Return Landscape
If you would invest 1,606 in Core Scientific, Common on December 1, 2024 and sell it today you would lose (490.00) from holding Core Scientific, Common or give up 30.51% of portfolio value over 90 days. Core Scientific, Common is currently does not generate positive expected returns and assumes 5.3447% risk (volatility on return distribution) over the 90 days horizon. In different words, 47% of stocks are less volatile than Core, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Core Scientific, Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Core Scientific,'s investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Core Scientific, Common, and traders can use it to determine the average amount a Core Scientific,'s price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0835
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CORZ |
Estimated Market Risk
| 5.34 actual daily | 47 53% of assets are more volatile |
Expected Return
| -0.45 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Core Scientific, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Core Scientific, by adding Core Scientific, to a well-diversified portfolio.
Core Scientific, Fundamentals Growth
Core Stock prices reflect investors' perceptions of the future prospects and financial health of Core Scientific,, and Core Scientific, fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Core Stock performance.
| Return On Asset | -0.0066 | ||||
| Profit Margin | (2.58) % | ||||
| Operating Margin | (0.42) % | ||||
| Current Valuation | 3.65 B | ||||
| Shares Outstanding | 294.12 M | ||||
| Price To Sales | 6.43 X | ||||
| Revenue | 502.4 M | ||||
| Gross Profit | 121.07 M | ||||
| EBITDA | (63.12 M) | ||||
| Net Income | (246.49 M) | ||||
| Cash And Equivalents | 29.55 M | ||||
| Cash Per Share | 0.08 X | ||||
| Total Debt | 865.54 M | ||||
| Current Ratio | 0.17 X | ||||
| Book Value Per Share | (2.80) X | ||||
| Cash Flow From Operations | 65.11 M | ||||
| Earnings Per Share | (4.39) X | ||||
| Market Capitalization | 3.28 B | ||||
| Total Asset | 712.16 M | ||||
| Retained Earnings | (2.42 B) | ||||
| Working Capital | (391.41 M) | ||||
About Core Scientific, Performance
Evaluating Core Scientific,'s performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Core Scientific, has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Core Scientific, has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 376.12 | 334.33 | |
| Return On Tangible Assets | (0.82) | (0.86) | |
| Return On Capital Employed | (0.01) | (0.01) | |
| Return On Assets | (0.82) | (0.86) | |
| Return On Equity | 1.60 | 0.92 |
Things to note about Core Scientific, Common performance evaluation
Checking the ongoing alerts about Core Scientific, for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Core Scientific, Common help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Core Scientific, generated a negative expected return over the last 90 days | |
| Core Scientific, has high historical volatility and very poor performance | |
| Core Scientific, has a very high chance of going through financial distress in the upcoming years | |
| Core Scientific, Common currently holds 865.54 M in liabilities. Core Scientific, Common has a current ratio of 0.17, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Core Scientific,'s use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 502.4 M. Net Loss for the year was (246.49 M) with profit before overhead, payroll, taxes, and interest of 121.07 M. | |
| Over 90.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Why Core Scientific, Inc. is Plunging So Far in 2025 |
- Analyzing Core Scientific,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Core Scientific,'s stock is overvalued or undervalued compared to its peers.
- Examining Core Scientific,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Core Scientific,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of Core Scientific,'s management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Core Scientific,'s stock. These opinions can provide insight into Core Scientific,'s potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Core Stock Analysis
When running Core Scientific,'s price analysis, check to measure Core Scientific,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific, is operating at the current time. Most of Core Scientific,'s value examination focuses on studying past and present price action to predict the probability of Core Scientific,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific,'s price. Additionally, you may evaluate how the addition of Core Scientific, to your portfolios can decrease your overall portfolio volatility.